RET and metastatic neoplasm: One patient had RET mutation – in the other two cases the genetic evaluation was not available; extended germline mutations in genes associated with PHEO development and a somatic genetic test would elucidate and extend the knowledge about genotype of patients with bilateral and metastatic disease.